Publication date: May 14, 2019
Gary Palmer, Chief Medical Officer at Tempus Inc., spoke at the 2019 Future of Individualized Medicine conference about the value of combined clinical and genomic data in accelerating precision medicine.
|Precision Medicine||Systems biology|
- Taking the Lead in Precision Medicine as a Surgeon
- Future of Individualized Medicine 2019 – Amalio Telenti
- Future of Individualized Medicine 2019 – Stephen Kingsmore
- Amgen And Syapse Enter Precision Medicine Collaboration In Oncology
- Comprehensive Tumor Profiling Promises New Therapeutic Options for Patients with Advanced Cancer